Waterstone Pharmaceutical (wuhan) Co., Ltd.

This study tests a new medicine called WS016 for people with high potassium levels (hyperkalemia). The trial has two parts: a short phase to quickly lower potassium, followed by a month-long phase to keep it in a safe range. About 420 adults with moderately high potassium will ta…